|1.||Yamaguchi, Hideyo: 7 articles (06/2012 - 01/2003)|
|2.||Koga, Hiroyasu: 4 articles (06/2012 - 01/2006)|
|3.||Uchida, Katsuhisa: 4 articles (06/2006 - 01/2003)|
|4.||Tavakkol, Amir: 3 articles (07/2014 - 04/2013)|
|5.||Nanjoh, Yasuko: 3 articles (06/2012 - 01/2006)|
|6.||Tsuboi, Ryoji: 3 articles (06/2012 - 01/2006)|
|7.||Gold, Michael H: 2 articles (12/2015 - 10/2014)|
|8.||Olin, Jason T: 2 articles (12/2015 - 07/2014)|
|9.||Scher, Richard K: 2 articles (07/2014 - 01/2002)|
|10.||Jones, Terry: 2 articles (07/2014 - 04/2013)|
|1.||Tinea Pedis (Athlete's Foot)
10/01/2014 - "Luliconazole cream 1% was safe and well-tolerated and demonstrated significantly greater efficacy than vehicle cream in patients with interdigital tinea pedis."
07/01/2014 - "This phase 3 study evaluated the safety and efficacy of luliconazole cream 1% in patients with tinea pedis. "
12/01/2015 - "Evidence from clinical trials in tinea pedis have shown once-daily application of luliconazole cream 1% for 14 days to be effective and well tolerated. "
12/01/2015 - "In this article, we summarize the in vitro data, animal studies and clinical trial data relating to the use of topical luliconazole cream 1% in the treatment of tinea pedis. "
10/01/2014 - "A Randomized, Double-blind, Vehicle-controlled Trial of Luliconazole Cream 1% in the Treatment of Interdigital Tinea Pedis."
09/01/2014 - "According to our meta-analysis, short-term treatment of luliconazole cream 1% can result in the complete clearance of dermatophytoses. "
09/01/2014 - "We evaluated the efficacy and safety of luliconazole cream 1% in the treatment of dermatophytoses. "
09/01/2014 - "Efficacy and tolerability of luliconazole cream 1% for dermatophytoses: a meta-analysis."
06/01/2012 - "Luliconazole is expected to be useful in the clinical management of dermatophytosis."
06/01/2012 - "These results clearly indicate that 1% luliconazole cream is sufficiently potent for short-term treatment for dermatophytosis compared to existing drugs. "
01/01/2014 - "Luliconazole cream 1% applied once daily for 7 days is more effective than vehicle and well tolerated in patients with tinea cruris."
06/01/2012 - "The dose-dependent therapeutic efficacy of topical luliconazole cream (0.02 to 1%), measured by macroscopic improvement of skin lesions and by fungal eradication as determined by a culture assay, was demonstrated using a tinea corporis model. "
01/01/2014 - "This phase 3 study evaluated the safety and efficacy of topical luliconazole cream 1% in patients with tinea cruris. "
01/01/2014 - "A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris."
01/01/2014 - "483 patients were enrolled and 256 male and female patients aged ≥12 years with clinically evident tinea cruris and eligible for modified intent-to-treat analysis were randomized 2:1 to receive luliconazole cream 1% (n=165) or vehicle (n=91) once daily for 7 days. "
07/01/2014 - "This article reviews the development of luliconazole solution, 10% its molecular properties, preclinical and clinical data and its future perspectives for the treatment of fungal infections. "
01/01/2014 - "Luliconazole for the treatment of fungal infections: an evidence-based review."
01/01/2003 - "In the latter group, after confirming infection had been established, the infected animals were topically treated with the NND-502 cream once daily for one week. "
08/01/1999 - "fumigatus activity of oral NND-502 in a murine model of systemic infection was apparently superior to that of FCZ and ITZ in terms of prolonging survival. "
06/23/2014 - "Luliconazole cream (Luzu) for tinea infections."
08/01/1999 - "In addition to the murine model of systemic aspergillosis, intravenous NND-502 was shown to be highly effective in a rat model of pulmonary aspergillosis compared with intravenous AmB; 90% of animals survived at a dose of 2.5 mg/kg per day of NND-502 while only 30% of animals escaped death when 5 mg/kg per day of AmB was used. "
|5.||Polyethylene Glycols (Polyethylene Glycol)